EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Rite Aid's enterprise value is €5,981 Mil.
Rite Aid's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was €-1,025 Mil. Therefore, Rite Aid's EV-to-EBITDA for today is -5.84.
The historical rank and industry rank for Rite Aid's EV-to-EBITDA or its related term are showing as below:
FRA:RTA1'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1056.03 Med: 10.9 Max: 39.27
Current: -5.82
During the past 13 years, the highest EV-to-EBITDA of Rite Aid was 39.27. The lowest was -1056.03. And the median was 10.90.
FRA:RTA1's EV-to-EBITDA is ranked worse than 100% of 462
companies
in the Healthcare Providers & Services industry
Industry Median: 12.84
vs FRA:RTA1: -5.82
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-22), Rite Aid's stock price is €0.20.
Rite Aid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was €-27.331. Therefore, Rite Aid's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Rite Aid EV-to-EBITDA Historical Data
The historical data trend for Rite Aid's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Rite Aid's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rite Aid's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Rite Aid's EV-to-EBITDA falls into.
Rite Aid EV-to-EBITDA Calculation
Rite Aid's EV-to-EBITDA for today is calculated as:
Rite Aid's current Enterprise Value is €5,981 Mil.
Rite Aid's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,025 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rite Aid (FRA:RTA1) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Rite Aid's share price for today is €0.20.
Rite Aid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-27.331.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Rite Aid's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:RTA1 has been successfully added to your 